FDA — authorised 4 June 1986
- Marketing authorisation holder: SCHERING
- Status: approved
🇺🇸 Intron A in United States
FDA authorised Intron A on 4 June 1986
Marketing authorisation
Intron A in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Intron A approved in United States?
Yes. FDA authorised it on 4 June 1986.
Who is the marketing authorisation holder for Intron A in United States?
SCHERING holds the US marketing authorisation.